Currie, Brooke
Davies, Evan
Beaudet, Amélie
Stassek, Larissa
Kleinman, Leah
Funding for this research was provided by:
Actelion Pharmaceuticals
Article History
Received: 15 February 2021
Accepted: 8 June 2021
First Online: 29 June 2021
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by central ethics (Ethical and Independent Review Services: 18158) and local ethics (Colorado Multiple Institutional Review Board: 18–2587; Cleveland Clinic Institutional Review Board: 19–1069) committees. Participant written informed consent was obtained prior to any study-related activities.
: Not applicable.
: LK and LS are employees of Evidera, which received funding from Actelion Pharmaceuticals Ltd., a Janssen Pharmaceutical Company of Johnson & Johnson, for the conduct of the study. BC is a former employee of Evidera. AB is an employee of Actelion Pharmaceuticals Ltd. and holds share in Johnson & Johnson. ED is a former employee of Actelion Pharmaceuticals Ltd.